Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for ELAN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 3.918B
March 31, 2026 3.991B
December 31, 2025 4.103B
September 30, 2025 4.024B
June 30, 2025 4.209B
March 31, 2025 4.395B
December 31, 2024 4.413B
September 30, 2024 4.357B
June 30, 2024 5.676B
March 31, 2024 5.765B
December 31, 2023 5.884B
September 30, 2023 5.909B
June 30, 2023 6.062B
March 31, 2023 6.02B
December 31, 2022 5.947B
September 30, 2022 5.901B
June 30, 2022 6.063B
Date Value
March 31, 2022 6.134B
December 31, 2021 6.446B
September 30, 2021 6.334B
June 30, 2021 6.097B
March 31, 2021 6.161B
December 31, 2020 6.278B
September 30, 2020 6.140B
June 30, 2020 2.056B
March 31, 2020 2.062B
December 31, 2019 2.417B
September 30, 2019 2.418B
June 30, 2019 2.467B
March 31, 2019 2.525B
December 31, 2018 2.472B
September 30, 2018 2.478B
June 30, 2018 0.00
March 31, 2018 0.00

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Zoetis, Inc. 9.238B
Eli Lilly & Co. 49.62B
ANI Pharmaceuticals, Inc. 610.49M
EyePoint, Inc. 19.81M
Amylyx Pharmaceuticals, Inc. 4.247M